Mitesh

The Department of Health and Social Care (DHSC) has via its Central Alerting System (CAS) published a letter advising that due to increasing flu levels in the community, Prescribers working in primary care may now prescribe, and community pharmacists may now supply antiviral medicines (oseltamivir and zanamivir) for the prophylaxis and treatment of influenza at [...]

The post DHSC permits use of antiviral medicines against influenza appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has today (25/11/2022) granted the following list of price concessions for November 2022: Drug Pack size Price concession Amoxicillin 500mg capsules 15 £1.85 Amoxicillin 500mg capsules 21 £2.59 Omeprazole 20mg gastro-resistant capsules 28 £2.60 Prednisolone 5mg soluble tablets 30 £62.00 Pregabalin 25mg capsules 56 £1.69 The DHSC [...]

The post November 2022 Price Concessions 3rd Update appeared first on PSNC Website.

In response to a significant ongoing disruption to the supply of Lipitor® 20mg chewable tablets , a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today, 23 November 2022, SSP039 provides that for every Lipitor® 20mg chewable tablet originally prescribed, either one Atorvastatin 20mg tablet or the equivalent [...]

The post New SSP issued for Lipitor® 20mg chewable tablets appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Estraderm MX® 50mcg patches are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP037 Estraderm MX® 50mcg patches expires at 23.59pm on Wednesday 23 November 2022. After this date, any prescriptions for Estraderm MX® 50mcg [...]

The post Contractor Notice: Expiry of SSP037 Estraderm MX® 50mcg patches appeared first on PSNC Website.

Class 4 Medicines Defect Information: Hyoscine Butylbromide 20 mg film-coated tablets (Morningside Healthcare Limited) Drug alert number: EL (22)A/48 Date issued: 21 November 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Hyoscine Butylbromide 20 mg film-coated tablets, PL 20117/0349 Batch Number Expiry Date Pack [...]

The post MHRA – Class 4 Medicines Defect Information: Hyoscine Butylbromide 20 mg film-coated tablets (Morningside Healthcare Limited) appeared first on PSNC Website.